In November 2024, the Moroccan Competition Council (Direction
Générale de la Concurrence et de la Répression
des Abus de Marché) imposed a fine of MAD 7.58 million
dirhams (approx. USD 760,000) on Viatris Inc., a US based
pharmaceutical company, for failing to notify the merger that
formed it. The fine was calculated as on 2.5% of the Moroccan
revenue of the businesses that were combined to form Viatris for
the year preceding the merger. This constitutes half of the maximum
fine possible, which would be 5% of annual Moroccan turnover.
Viatris did not appealed the decision has since paid the fine and
has since paid the fine.
End of 2020 Pfizer Inc. spun out its Upjohn Business and merged
it with Mylan N.V. The combined company was renamed Viatris. In the
distribution, Pfizer stockholders received approx. 0.124079 shares
of Viatris common stock for every one share of Pfizer common stock
held as of the close of business on the record date, which was 13
November 2020.
